VIR Q4 2020 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$301,000-69.3% YoY

Gross Profit

$301,000100.0% margin

Operating Income

-$108M-36014.6% margin

Net Income

-$106M-35099.3% margin

EPS (Diluted)

$-0.83

QoQ Revenue Growth

+60.1%

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$84M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$919M

Total Liabilities

$202M

Stockholders' Equity

$717M

Cash & Equivalents

$437M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$301,000	$980,000	-69.3%
Gross Profit	$301,000	-$53M	+100.6%
Operating Income	-$108M	-$64M	-70.0%
Net Income	-$106M	-$64M	-65.7%